This inventor holds 2 USPTO granted patents. Top assignee: British Technology Group Limited. Active years: 1994-1995.
Company Filing History:
Years Active: 1994-1995
Title: Howard N Stevens: Innovator in Controlled Release Devices
Introduction
Howard N Stevens is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled release devices. With a total of 2 patents to his name, Stevens has demonstrated a commitment to advancing medical solutions.
Latest Patents
Stevens' latest patents include innovative dispensing devices designed for controlled release of active materials. The first patent describes a controlled release device that comprises a water impermeable capsule with at least one orifice, which is closed by a water swellable or water dispersable plug. This capsule is typically cylindrical and made of polyethylene, closed at one end, with the open end sealed by a tablet formed from pharmaceutical excipients like lactose. The second patent outlines novel devices formed from at least two interpenetrating pieces, where the male piece is water swellable and swells to disengage the female piece. The female piece is preferably made from thermoplastic materials or soluble substances like gelatin, which is rendered impermeable by an external hydrophobic coating. These devices are particularly useful as oral dosage forms for humans.
Career Highlights
Stevens is associated with British Technology Group Limited, where he has been instrumental in developing innovative pharmaceutical technologies. His work has contributed to advancements in drug delivery systems, enhancing the efficacy and safety of medications.
Collaborations
Stevens has collaborated with notable colleagues, including Abdul Rashid and Marion E McNeill. Their combined expertise has fostered a productive environment for innovation and development in the field of pharmaceutical technology.
Conclusion
Howard N Stevens is a distinguished inventor whose work in controlled release devices has the potential to significantly impact the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving drug delivery systems for better patient outcomes.